SpringWorks Therapeutics Inc - ESG Rating & Company Profile powered by AI
This ESG rating for SpringWorks Therapeutics Inc indicates its reporting of the United Nations Sustainable Development Goals. The ESG score includes 17 UN Sustainable Development Goals including: 'Good Health & Wellbeing', 'Industry, Innovation & Infrastructure' and 'Partnerships for the Goals'. If you are employed by SpringWorks Therapeutics Inc and you would like to licence your Sustainability aseessment, please contact us.
SpringWorks Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.9; made up of an environmental score of 1.3, social score of 3.4 and governance score of 4.0.
2.9
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1336 | SyneuRx International (Taiwan) Corp | 3.0 | Medium |
1336 | Sensorion SA | 3.0 | Medium |
1353 | SpringWorks Therapeutics Inc | 2.9 | Medium |
1353 | Caribou Biosciences Inc | 2.9 | Medium |
1353 | Checkmate Pharmaceuticals Inc | 2.9 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
Frequently Asked Questions
Does SpringWorks Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes SpringWorks Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes SpringWorks Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes SpringWorks Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes SpringWorks Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes SpringWorks Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes SpringWorks Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes SpringWorks Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes SpringWorks Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes SpringWorks Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes SpringWorks Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes SpringWorks Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes SpringWorks Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes SpringWorks Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes SpringWorks Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes SpringWorks Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes SpringWorks Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid SpringWorks Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes SpringWorks Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes SpringWorks Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas SpringWorks Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes SpringWorks Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes SpringWorks Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes SpringWorks Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes SpringWorks Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes SpringWorks Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes SpringWorks Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes SpringWorks Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs SpringWorks Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes SpringWorks Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes SpringWorks Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes SpringWorks Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes SpringWorks Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes SpringWorks Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes SpringWorks Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes SpringWorks Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for SpringWorks Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also developing mirdametinib, an oral small molecule MEK inhibitor that is in Phase 2b clinical trials for the treatment of neurofibromatosis type 1-associated plexiform neurofibromas, as well as Phase 1/2a clinical trial for the treatment of NF1-PN; mirdametinib + lifirafenib, a combination therapy that is in Phase 1b/2 clinical trial in patients with advanced or refractory solid tumors; and mirdametinib in monotherapy and combination approaches to treat solid tumors. In addition, it develops BGB-3245, an oral selective small molecule inhibitor of monomeric and dimeric forms of activating BRAF mutations, which is in Phase I clinical trial. The company has collaborations with BeiGene, Ltd., GlaxoSmithKline LLC, and Allogene to develop combination approaches with nirogacestat and mirdametinib; and license agreements with Pfizer Inc. for nirogacestat and mirdametinib. It also has a license agreement with Katholieke Universiteit Leuven and the Flanders Institute for Biotechnology for a portfolio of novel small molecule inhibitors of the TEA Domain; and Dana-Farber Cancer Institute for a portfolio of novel small molecule inhibitors of Epidermal Growth Factor Receptor. In addition, the company has clinical collaboration agreement with Janssen Biotech, Inc., Precision BioSciences, Inc., Seagen Inc., and AbbVie, Inc. SpringWorks Therapeutics, Inc. was founded in 2017 and is headquartered in Stamford, Connecticut.